Search results
Prof. Christoph Huber, M.D., Dr. h. c., is a co-founder of BioNTech and has served as a member of our Supervisory Board since 2008. He has more than 50 years of professional experience in hematology, oncology and translational immunology.
Prof. Christopher Huber is a hematologist, oncologist and immunologist with over 50 years of experience. He co-founded BioNTech in 2008 and Ganymed Pharmaceuticals in 2009, and serves on several boards and committees in the biotech sector.
Christoph Huber MD, FMH, FECTS is a Swiss cardiac surgeon who is a professor and the head of the Division of Cardiac and Vascular Surgery at the University Hospital Geneva, Switzerland. Huber also maintains a research program, is an inventor, book author and entrepreneur, having founded the company Endoheart AG.
Christoph Huber (* 14. Februar 1944 in Wien) ist ein österreichischer Hämatologe, Onkologe und Immunologe mit den Forschungsschwerpunkten Tumor -Abwehr und Stammzelltransplantation. Von 1990 bis zu seiner Emeritierung im Jahr 2009 war er Direktor der III.
Christoph Huber holds 4 board and advisor roles including Member Supervisory Board at TRON customer service, Vice Chairman of the Supervisory Board at Ganymed Pharmaceuticals, and Member of the Scientific Advisory Board at immatics biotechnologies.
- Male
- Mainz, Rheinland-Pfalz
Prof. Christoph Huber, M.D., leaves BioNTech’s Supervisory Board upon reaching retirement age limit; he will become a member in BioNTech’s scientific advisory board. Shareholders passed all other resolutions of the Annual General Meeting.
Dec 12, 2019 · The Swiss are scrutinizing earlier allegations that the trader, Christoph Huber, was involved in the illegal trade of minerals during the Congo conflict two decades ago, a...
